Rx0000216 |
Deciphera Pharmaceuticals, LLC |
04/25/2025 |
73207010130 |
Qinlock Oral Tablet 50 MG, 90 Each, Bottle |
01/01/2025 |
1485.00 |
43470.00 |
10/06/2042 |
Single Source Drug |
None |
None |
None |
1 |
The establishment of price and associated price changes may take into consideration a number of factors such as current market dynamics, competitive environment, the clinical and economic value of therapy, therapeutic category, payer environment, government rebates, patient support, overall research and development costs, as well as business operational continuation needs. In our commitment to patients and ensuring patient access, we have a patient support program that provides reimbursement and financial assistance programs for eligible patients. |
None |
None |
1 |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
Rx0000492 |
Dynavax Technologies Corporation |
02/21/2025 |
43528000305 |
HEPLISAV-B [Hepatitis B Vaccine (Recombinant)] Adjuvanted 20 MCG / 0.5 ML PFS. 5 syringes/carton |
01/15/2025 |
40.60 |
778.75 |
04/16/2032 |
Innovator Multiple Source Drug |
None |
None |
392831796 |
None |
Planned increase is due to increasing business costs and inflationary effects. |
None |
There is no change or improvement that necessitated the price increase. |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |